Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.74M Buy
43,749
+1,026
+2% +$62.6K 0.58% 21
2016
Q3
$2.69M Buy
42,723
+13,102
+44% +$848K 0.57% 22
2016
Q2
$1.83M Buy
29,621
+829
+3% +$50.5K 0.37% 38
2016
Q1
$1.65M Buy
28,792
+27,048
+1,551% +$1.51M 0.33% 36
2015
Q4
$103K Sell
1,744
-1,074
-38% -$61.9K 0.02% 206
2015
Q3
$153K Sell
2,818
-300
-10% -$19.5K 0.03% 159
2015
Q2
$209K Sell
3,118
-553
-15% -$36.1K 0.04% 152
2015
Q1
$215K Sell
3,671
-524
-12% -$31.7K 0.04% 153
2014
Q4
$275K Sell
4,195
-2,391
-36% -$151K 0.06% 156
2014
Q3
$380K Sell
6,586
-11,616
-64% -$645K 0.07% 138
2014
Q2
$1.03M Sell
18,202
-13
-0.1% -$682 0.19% 63
2014
Q1
$936K Sell
18,215
-14,228
-44% -$719K 0.18% 72
2013
Q4
$1.71M Buy
+32,443
New +$1.59M 0.34% 40

Other funds holding ABBV

Kanaly Trust's ABBV Position: Q4 2016 in Review

Kanaly Trust increased its AbbVie (ABBV) stake by 2.4% in Q4 2016, buying an estimated $62.6K and bringing the position to 43,749 shares worth $2.74M. The position accounts for 0.58% of the portfolio, ranked #21.

Kanaly Trust first reported a position in ABBV in Q4 2013 and has held it in 13 quarters since. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • Kanaly Trust held 43,749 shares of AbbVie worth $2.74M as of Q4 2016.
  • Kanaly Trust bought 1,026 AbbVie shares in Q4 2016, an estimated $62.6K.
  • AbbVie made up 0.58% of Kanaly Trust's portfolio in Q4 2016, its #21 holding.
  • Kanaly Trust first reported a position in AbbVie in Q4 2013 and has held it in 13 quarters since.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.